Power 3 Medical Products Inc. PWRM.OB
Power 3 Medical Products Inc. (PWRM.OB), strives to become the premier biotechnology company specializing in the commercialization of proteomics IP for the diagnosis and treatment of disease by using cutting edge technologies, world class quality procedures and superior research methodologies. PWRM will be guided in all of its dealings with its customers, partners, shareholders, associates and investors by the philosophy of best practices.
PWRM, a bio-technology company, engages in the development and marketing of diagnostic tests in the fields of cancer, neurodegenerative and neuromuscular diseases in the United States. PWRM�s products include BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer; and NuroPro, a serum test for the detection of neurodegenerative diseases, such as amyotrophic lateral sclerosis, Alzheimer�s disease, and Parkinson�s disease. PWRM�s products analyze proteins and their mutations to assess an individuals risk for developing disease later in life or a patient�s likelihood of responding to a particular drug; assess a patient�s risk of disease progression and disease recurrence; and measure a patient?s exposure to drug therapy. PWRM was formerly known as Surgical Safety Products, Inc. and changed its name to Power3 Medical Products, Inc. in September 2003. PWRM was founded in 1992 & is based in The Woodlands, Texas.
Last Trade: 0.0250
Abbott Laboratories, (NYSE:ABT)
Imagine needing a critical test at your local hospital, but having to wait days to be tested because there was no laboratory professional available to run the tests. This scene seems unimaginable, but it’s a reality in some parts of the United States, such as California.
The Abbott Fund is helping reverse this trend by supporting California’s Healthcare Laboratory Workforce Initiative (HLWI), which has helped to more than double the number of hospitals that provide on-site clinical training for aspiring laboratory science workers.
The boost in California’s lab workforce is helping to ease a serious staffing crisis. The closing of training programs at universities and hospitals, as well as aging lab technologists without an ample supply of successors, led to an average shortage of four full-time employees per hospital laboratory in the state. By helping to establish new training sites, HLWI is motivating hospitals to develop and retain their own staff. Offering training opportunities with pathways toward full-time employment lowers recruitment costs and shortens the learning curve for new workers.
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. It operates in four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.
Last Trade: 49.84
The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of this Web-Site or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company or person mentioned or referred to in the article.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
No comments:
Post a Comment